We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What Drove Columbia Financial’s (NASDAQ:CLBK) 9% Stock Move on Monday?

Columbia Financial (NASDAQ:CLBK) experienced an active trading session after releasing its latest financial results alongside news of a planned acquisition. Shares rose by nearly 9% during the session, reflecting market response to both the earnings update and the strategic transaction announcement.

Aditi Sarkar | 03 February 2026

Should You Hold This Dividend Mining Stock After Its 2025 Rally?

Hecla Mining (NYSE:HL) operates as a precious metals producer with a primary focus on silver. During the third quarter of 2025, silver accounted for roughly half of company revenue, while gold represented just over one-third. Lead and zinc contributed the remainder. As a result, …

Aditi Sarkar | 03 February 2026

Is Corning (NYSE:GLW) a Buy After Its USD 6 Bn Meta AI Deal?

Corning Incorporated (NYSE:GLW) has long been associated with specialty glass products used in consumer electronics. Over recent years, however, the company has increased its exposure to optical communications, supplying fiber-optic cables used in data centres and enterprise networks. These products are designed to transmit …

Aditi Sarkar | 03 February 2026

NVIDIA Corp (NASDAQ:NVDA) Tracks AI-Led Demand Amid Market Swings

NVIDIA Corp (NASDAQ:NVDA) operates in the semiconductor sector, designing graphics processing units that enable parallel computing. While GPUs were initially developed for gaming graphics, their architecture has made them suitable for tasks requiring large-scale computational power. Over time, these processors have been adopted for …

Aditi Sarkar | 03 February 2026

SouthState Bank (NYSE:SSB) Sees Analyst Target Revisions Amid Shifting Share Price Trends

SouthState Bank (NYSE:SSB) is a U.S.-based bank holding company headquartered in Winter Haven, Florida. Through its primary subsidiary, SouthState Bank, the company provides commercial and retail banking services to businesses, institutions, and individual customers. Its core activities include commercial and industrial lending, commercial real …

Aditi Sarkar | 03 February 2026

Protagonist Therapeutics (NASDAQ: PTGX) Under the Lens: How Do Analyst Targets Compare With Recent Price Trends?

Protagonist Therapeutics (NASDAQ:PTGX) is a clinical-stage biopharmaceutical company focused on developing orally administered peptide-based therapies for immune-mediated and other serious diseases. The company applies its proprietary Peptide 2.0 platform to design molecules targeting G protein–coupled receptors and cytokine receptors, aiming to provide oral alternatives …

Aditi Sarkar | 03 February 2026

How Is NXP (NASDAQ:NXPI) Finding Growth Pockets Despite a Challenging Year?

NXP Semiconductors N.V. (NASDAQ:NXPI) reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth-quarterrevenuereached USD 3.34 billion, reflecting a 7 percent increase compared with the same period last year and a sequential rise from the previous quarter. Full-year revenue …

Team Kalkine | 02 February 2026

How Is Flexsteel (NASDAQ:FLXS) Growing Margins Even as Cost Pressures Persist?

Flexsteel Industries, Inc. (NASDAQ:FLXS), a U.S.-based residential furniture manufacturer and importer, reported its financial results for the fiscal second quarter ended December 31, 2025. Net sales for the quarter reached USD 118.2 million, compared with USD 108.5 million in the same period last year, …

Team Kalkine | 02 February 2026

What’s Behind Palantir’s (NASDAQ:PLTR) Recent Momentum in the U.S. Market?

Palantir Technologies Inc (NASDAQ:PLTR) reported sharp year-over-year growth in U.S. commercialrevenueduring Q4 2025, alongside elevated total revenue expansion. The company also issued FY 2026 revenue guidance indicating continued acceleration in U.S. commercial activity. Profitability metrics, cash generation, and contract values showed material increases across …

Team Kalkine | 02 February 2026

Europe Pushes Back on Acadia (NASDAQ:ACAD)’s Rett Syndrome Therapy — Here’s Why

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) reported that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) indicated a negative trend vote on its Marketing Authorization Application (MAA) for trofinetide, intended for the treatment of Rett syndrome. The feedback follows the recent …

Team Kalkine | 02 February 2026
Support

Hi! How can we help you today?

Loading…